MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation
- 29 October 2001
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 29 (3), 287-294
- https://doi.org/10.1038/ng762
Abstract
The gene MID1, the mutation of which causes X-linked Opitz G/BBB syndrome (OS, MIM 300000), encodes a microtubule-associated protein (MAP). We show that mutation of MID1 leads to a marked accumulation of the catalytic subunit of protein phosphatase 2A (PP2Ac), a central cellular regulator. PP2Ac accumulation is caused by an impairment of a newly identified E3 ubiquitin ligase activity of the MID1 protein that normally targets PP2Ac for degradation through binding to its α4 regulatory subunit in an embryonic fibroblast line derived from a fetus with OS. Elevated PP2Ac causes hypophosphorylation of MAPs, a pathological mechanism that is consistent with the OS phenotype.Keywords
This publication has 47 references indexed in Scilit:
- Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's DiseaseScience, 2001
- Cbl-b, a RING-type E3 Ubiquitin Ligase, Targets Phosphatidylinositol 3-Kinase for Ubiquitination in T CellsJournal of Biological Chemistry, 2001
- RING Finger ProteinsCell, 2000
- Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53Journal of Biological Chemistry, 2000
- A gene for FG syndrome maps in the Xq12-q21.31 regionAmerican Journal of Medical Genetics, 1997
- Opitz G/BBB syndrome, a defect of midline development, is due to mutations in a new RING finger gene on Xp22Nature Genetics, 1997
- HOX11 interacts with protein phosphatases PP2A and PP1 and disrupts a G2/M cell-cycle checkpointNature, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996
- Opitz syndrome is genetically heterogeneous, with one locus on Xp22, and a second locus on 22q11.2Nature Genetics, 1995
- Regulation of cytoskeletal organization in tumor cells by protein phosphatases‐1 and ‐2AInternational Journal of Cancer, 1995